More News

22 Dec 2020 Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
18 Dec 2020 Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology
18 Dec 2020 Histogen Announces Filing an Investigational New Drug Application for HST-003
18 Dec 2020 ONK Therapeutics Announces Three Exclusive Option License Agreements, Which Extend and Strengthen its Dual-Targeted NK Cell Therapy Pipeline
18 Dec 2020 Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
18 Dec 2020 Leading BioSciences and Seneca Biopharma Announce Merger
16 Dec 2020 Lilly Announces Agreement to Acquire Prevail Therapeutics
14 Dec 2020 Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
12 Dec 2020 AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
10 Dec 2020 Gilead Sciences to Acquire MYR GmbH
10 Dec 2020 Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates
08 Dec 2020 Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes
08 Dec 2020 PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
08 Dec 2020 Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
08 Dec 2020 Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases
04 Dec 2020 Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
04 Dec 2020 PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration and License Agreement for SOL-578, a Chk1 inhibitor
03 Dec 2020 Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
03 Dec 2020 Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation
02 Dec 2020 AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
01 Dec 2020 Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies
01 Dec 2020 Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
01 Dec 2020 Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
28 Nov 2020 Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
23 Nov 2020 Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top